Recent discussions on X about MicroStrategy (MSTR) have centered on the company's potential inclusion in the S&P 500, sparking intense interest among investors. Many users are highlighting the firm's impressive financials, including strong revenue figures and substantial Bitcoin holdings, as key reasons for optimism. The buzz suggests a possible surge in demand if the inclusion happens, though some caution about short-term volatility.
Additionally, there’s a mix of speculation regarding the stock’s price movements, with some on X pointing to technical indicators and others noting potential suppression by larger market players. The conversation remains dynamic, as the correlation between MSTR’s performance and Bitcoin’s price continues to be a focal point. This blend of hope and skepticism keeps the dialogue engaging and multifaceted.
Note: This discussion summary was generated from an AI condensation of post data.
MicroStrategy Congressional Stock Trading
Members of Congress have traded $MSTR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MSTR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MicroStrategy Insider Trading Activity
MicroStrategy insiders have traded $MSTR stock on the open market 144 times in the past 6 months. Of those trades, 19 have been purchases and 125 have been sales.
Here’s a breakdown of recent trading of $MSTR stock by insiders over the last 6 months:
- WEI-MING SHAO (EVP & General Counsel) has made 3 purchases buying 6,527 shares for an estimated $567,295 and 52 sales selling 107,152 shares for an estimated $42,444,346.
- PETER L JR BRIGER purchased 220,000 shares for an estimated $19,800,000
- JEANINE MONTGOMERY (VP & CAO) has made 1 purchase buying 5,000 shares for an estimated $450,000 and 11 sales selling 44,571 shares for an estimated $19,121,847.
- ANDREW KANG (EVP & CFO) has made 3 purchases buying 6,550 shares for an estimated $570,750 and 18 sales selling 34,700 shares for an estimated $13,555,997.
- JARROD M PATTEN has made 3 purchases buying 20,555 shares for an estimated $1,938,730 and 28 sales selling 27,950 shares for an estimated $10,723,302.
- CARL J RICKERTSEN has made 0 purchases and 3 sales selling 27,370 shares for an estimated $10,199,235.
- LESLIE J RECHAN has made 0 purchases and 3 sales selling 15,000 shares for an estimated $5,038,440.
- PHONG LE (President & CEO) has made 6 purchases buying 16,119 shares for an estimated $1,398,808 and 10 sales selling 8,576 shares for an estimated $3,063,506.
- GREGG WINIARSKI purchased 10,000 shares for an estimated $976,520
- JANE A DIETZE purchased 1,500 shares for an estimated $135,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MicroStrategy Hedge Fund Activity
We have seen 737 institutional investors add shares of MicroStrategy stock to their portfolio, and 426 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CLEAR STREET LLC added 5,971,971 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,414,049,837
- CLEAR STREET DERIVATIVES LLC removed 5,283,815 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,135,876,537
- VANGUARD GROUP INC removed 2,047,255 shares (-9.9%) from their portfolio in Q2 2025, for an estimated $827,561,888
- JPMORGAN CHASE & CO added 2,024,218 shares (+180.1%) to their portfolio in Q2 2025, for an estimated $818,249,642
- CITADEL ADVISORS LLC removed 1,547,066 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $625,370,489
- MORGAN STANLEY added 1,511,317 shares (+19.7%) to their portfolio in Q2 2025, for an estimated $610,919,670
- FMR LLC added 1,499,669 shares (+266.5%) to their portfolio in Q2 2025, for an estimated $606,211,199
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MicroStrategy Government Contracts
We have seen $29,200 of award payments to $MSTR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MICROSTRATEGY TECHNICAL SUPPORT STANDARD RENEWAL - FY25 HHS PROGRAM PERFORMANCE TRACKING SYSTEM: $29,200
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
MicroStrategy Analyst Ratings
Wall Street analysts have issued reports on $MSTR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 08/26/2025
- Mizuho issued a "Outperform" rating on 08/11/2025
- Benchmark issued a "Buy" rating on 08/01/2025
- BTIG issued a "Buy" rating on 08/01/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/28/2025
- TD Cowen issued a "Buy" rating on 07/15/2025
- Barclays issued a "Overweight" rating on 05/05/2025
To track analyst ratings and price targets for MicroStrategy, check out Quiver Quantitative's $MSTR forecast page.
MicroStrategy Price Targets
Multiple analysts have issued price targets for $MSTR recently. We have seen 8 analysts offer price targets for $MSTR in the last 6 months, with a median target of $633.0.
Here are some recent targets:
- Joseph Vafi from Canaccord Genuity set a target price of $464.0 on 08/26/2025
- Dan Dolev from Mizuho set a target price of $586.0 on 08/11/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $697.0 on 08/01/2025
- Andrew Harte from BTIG set a target price of $700.0 on 08/01/2025
- Mark Palmer from Benchmark set a target price of $705.0 on 08/01/2025
- Lance Vitanza from TD Cowen set a target price of $680.0 on 07/15/2025
- Ramsey El-Assal from Barclays set a target price of $475.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
